Recruiting

Somatic Health Screening for Adults in Outpatient Psychiatric Care in Denmark (SomaScreen)

ClinicalTrials.gov IDNCT07518446

PhaseNA

Enrollment2800

SponsorAmager Hospital

Age18 Years

SexALL

I'm interested View official listing

Conditions studied

Atrial Fibrillation (AF), Heart Failure, Asthma (Diagnosis), Chronic Obstructive Pulmonary Disease (COPD), Diabetes, Cancer, Psychiatric Patients, Serious Medical Illness

About this study

People with severe mental illness have a substantially increased risk of undiagnosed and insufficiently treated somatic disease. Somatic Screening in the Capital Region Mental Health Service in Denmark (SomaScreen) is a service-level intervention implemented in psychiatric outpatient clinics in the Capital Region of Denmark to improve the detection and follow-up of somatic disease among patients with psychotic and affective disorders. This study evaluates whether integrating structured somatic screening into mental health services leads to improved identification and management of somatic disease compared with care as usual. Using a quasi-experimental controlled design with a matched cohort, outcomes among patients exposed to the SomaScreen intervention are compared with those of patients receiving usual care in comparable psychiatric outpatient clinics outside the Capital Region.

Interventions

Diagnostic Test: Somatic Health Screening for Adults in Outpatient Psychiatric Care in Denmark (SomaScreen) — SomaScreen is a structured somatic health screening program for adults in psychiatric outpatient care (F-ACT and OPUS clinics). Trained somatic nurses and general practitioner consultants systematically assess patients for cardiovascular disease, asthma, chronic obstructive pulmonary disease (COPD), diabetes, and cancer, and may detect other somatic conditions. Patients with identified conditions are referred to their own general practitioner for follow-up and management. The intervention is distinguished from usual care by its systematic, multi-condition screening and structured referral process.

Primary outcomes

Previously Undiagnosed Somatic Illness (2 years from start of intervention)
Management of Somatic Conditions (2 years from start of intervention)

Eligibility information

Inclusion Criteria: * Patients aged 18 years or older. * Referred to FACT or OPUS psychiatric outpatient clinics in the Capital Region of Denmark. * Starting a new outpatient treatment episode in FACT or OPUS. * Diagnosed with psychotic or affective disorders (ICD-10 F20-F39), including those with comorbid substance use disorders (F10-F19). Exclusion Criteria: * Individuals younger than 18 years. * Patients in geriatric outpatient clinics. * Individuals not in the target diagnosis group (i.e., without psychotic or affective disorders, F20-F39). * Individuals who do not meet the inclusion criteria above.

Study locations

Amager Hospital, Copenhagen, 2300 Denmark

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.